Founded in 2016, Spindiag is a spin-off from the renowned research institute Hahn-Schickard. From the vision of seven scientists, a young innovative medical technology start-up was formed, consisting of a highly motivated continuously growing team of more than 100 employees today. Spindiag comprises a team with valuable know-how from different fields in science, research & development, production, marketing, quality, sales, and services supported by external advisors.
We aim to arm the world with an effective tool against epidemic and pandemic infectious diseases: for this purpose, we introduced the point-of-care testing system Rhonda, quickly delivering reliable in-vitro diagnostic PCR results in well under one hour. We envision, that patients will be safer thanks to Rhonda, the new gold standard for routine infection control. Providing a safe, simple, and efficient solution to healthcare workers, to perform routine infection control.
In doing so, we follow our mission every day to improve world health by simply providing diagnostic results.